These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38149578)

  • 1. The protective effects of pediatric vaccination on multisystem inflammatory syndrome in children stratified by vaccine status, types and virus variants.
    Zhang YF; Xia CY; Yang Q; Cai Y; Li DT; Jiang Q; Hu P
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111105. PubMed ID: 38149578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022.
    Zambrano LD; Newhams MM; Olson SM; Halasa NB; Price AM; Orzel AO; Young CC; Boom JA; Sahni LC; Maddux AB; Bline KE; Kamidani S; Tarquinio KM; Chiotos K; Schuster JE; Cullimore ML; Heidemann SM; Hobbs CV; Nofziger RA; Pannaraj PS; Cameron MA; Walker TC; Schwartz SP; Michelson KN; Coates BM; Flori HR; Mack EH; Smallcomb L; Gertz SJ; Bhumbra SS; Bradford TT; Levy ER; Kong M; Irby K; Cvijanovich NZ; Zinter MS; Bowens C; Crandall H; Hume JR; Patel MM; Campbell AP; Randolph AG;
    Clin Infect Dis; 2023 Feb; 76(3):e90-e100. PubMed ID: 35924406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS).
    Ludwikowska KM; Popiel A; Matkowska-Kocjan A; Biela M; Wójcik M; Szenborn F; Wielgos K; Pielka-Markiewicz E; Zaryczański J; Kursa MB; Szenborn L
    Vaccine; 2023 May; 41(21):3317-3327. PubMed ID: 37087396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study.
    Nygaard U; Holm M; Hartling UB; Glenthøj J; Schmidt LS; Nordly SB; Matthesen AT; von Linstow ML; Espenhain L
    Lancet Child Adolesc Health; 2022 Jul; 6(7):459-465. PubMed ID: 35526537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisystemic inflammatory syndrome in children and the BNT162b2 vaccine: a nationwide cohort study.
    Schwartz N; Ratzon R; Hazan I; Zimmerman DR; Singer SR; Wasser J; Dweck T; Alroy-Preis S
    Eur J Pediatr; 2024 Aug; 183(8):3319-3326. PubMed ID: 38724677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multisystem Inflammatory Syndrome in an Adolescent Following SARS-CoV-2 Exposure Despite Three Doses of a COVID-19 Vaccine.
    Goel AR; Chiang SS; Ibrahim O; Yalcindag A
    R I Med J (2013); 2022 Jun; 105(5):41-45. PubMed ID: 35617041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
    Zambrano LD; Newhams MM; Olson SM; Halasa NB; Price AM; Boom JA; Sahni LC; Kamidani S; Tarquinio KM; Maddux AB; Heidemann SM; Bhumbra SS; Bline KE; Nofziger RA; Hobbs CV; Bradford TT; Cvijanovich NZ; Irby K; Mack EH; Cullimore ML; Pannaraj PS; Kong M; Walker TC; Gertz SJ; Michelson KN; Cameron MA; Chiotos K; Maamari M; Schuster JE; Orzel AO; Patel MM; Campbell AP; Randolph AG;
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(2):52-58. PubMed ID: 35025852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.
    Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP; Edwards KM; Creech CB; Staat MA; Belay ED; Marquez P; Su JR; Salzman MB; Thompson D; Campbell AP;
    Lancet Child Adolesc Health; 2022 May; 6(5):303-312. PubMed ID: 35216660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study.
    Kildegaard H; Lund LC; Højlund M; Stensballe LG; Pottegård A
    BMJ; 2022 Apr; 377():e068898. PubMed ID: 35410884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children.
    Bellusci L; Grubbs G; Sait S; Yonker LM; Randolph AG; Novak T; Kobayashi T; ; Khurana S
    Nat Commun; 2023 Dec; 14(1):7952. PubMed ID: 38040697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of Adverse Reactions After COVID-19 Vaccination Among Patients With a History of Multisystem Inflammatory Syndrome in Children.
    Elias MD; Truong DT; Oster ME; Trachtenberg FL; Mu X; Jone PN; Mitchell EC; Dummer KB; Sexson Tejtel SK; Osakwe O; Thacker D; Su JA; Bradford TT; Burns KM; Campbell MJ; Connors TJ; D'Addese L; Forsha D; Frosch OH; Giglia TM; Goodell LR; Handler SS; Hasbani K; Hebson C; Krishnan A; Lang SM; McCrindle BW; McHugh KE; Morgan LM; Payne RM; Sabati A; Sagiv E; Sanil Y; Serrano F; Newburger JW; Dionne A;
    JAMA Netw Open; 2023 Jan; 6(1):e2248987. PubMed ID: 36595296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Autoantibody Binding to Cardiac Tissue in Multisystem Inflammatory Syndrome in Children and COVID-19 Vaccination-Induced Myocarditis.
    Patel H; Sintou A; Chowdhury RA; Rothery S; Iacob AO; Prasad S; Rainer PP; Martinón-Torres F; Sancho-Shimizu V; Shimizu C; Dummer K; Tremoulet AH; Burns JC; Sattler S; Levin M;
    JAMA Netw Open; 2023 May; 6(5):e2314291. PubMed ID: 37200028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of multisystem inflammatory syndrome in children associated to COVID-19 in Chile: Epidemiologic trends during pandemic, before and after children vaccination.
    Villena R; Izquierdo G; Wilhelm J; García C; Acuña M; Riquelme P; Alvarado S; Torres JP
    Vaccine; 2024 Sep; 42(22):126015. PubMed ID: 38852034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of multisystem inflammatory syndrome and other autoimmune diseases after SARS-CoV-2 infection compared to COVID-19 vaccination in children and adolescents in south central Europe.
    Bizjak M; Emeršič N; Zajc Avramovič M; Barbone F; Ronchese F; Della Paolera S; Conversano E; Amoroso S; Vidoni M; Vesel Tajnšek T; Mlakar G; Berce V; Markelj G; Plankar Srovin T; Golli T; Osredkar D; Koren Jeverica A; Toplak N; Pokorn M; Avšič Županc T; Ihan A; Fafangel M; Taddio A; Avčin T
    Clin Exp Rheumatol; 2023 May; 41(5):1183-1191. PubMed ID: 36377567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12-17 years in Singapore: a national cohort study.
    Chiew CJ; Premikha M; Chong CY; Wei WE; Ong B; Lye DC; Heng D; Lee VJ; Tan KB
    Lancet Infect Dis; 2023 Feb; 23(2):177-182. PubMed ID: 36182678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants in Children With Coronavirus Disease 2019, Multisystem Inflammatory Syndrome in Children, and After Two Doses of BNT162b2 Vaccination.
    Rostad CA; Chen X; Sun HY; Hussaini L; Lu A; Perez MA; Hsiao HM; Anderson LJ; Anderson EJ
    J Infect Dis; 2022 Sep; 226(7):1237-1242. PubMed ID: 35639597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5-11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022.
    Cortese MM; Taylor AW; Akinbami LJ; Thames-Allen A; Yousaf AR; Campbell AP; Maloney SA; Harrington TA; Anyalechi EG; Munshi D; Kamidani S; Curtis CR; McCormick DW; Staat MA; Edwards KM; Creech CB; Museru O; Marquez P; Thompson D; Su JR; Schlaudecker EP; Broder KR
    J Infect Dis; 2023 Jul; 228(2):143-148. PubMed ID: 36821777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.